We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > IIBR

News List

NRx and Israel partner to advance Covid-19 vaccine development pharmaceutical-technology
July 13, 2021
NRx Pharmaceuticals has entered a memorandum of understanding with the Government of Israel to licence exclusive global development, manufacturing and commercialisation rights to a Covid-19 vaccine, BriLife.
Israeli scientists say Gaucher’s disease drugs may help treat Covid-19 pharmaceutical-technology
May 29, 2020
Scientists from the Israeli Institute for Biological Research (IIBR) claim that analogues of two drugs used for the treatment of Gaucher’s disease could be effective against Covid-19.
Israeli scientists begin animal testing of Covid-19 vaccine prototype pharmaceutical-technology
April 03, 2020
The Israel Institute for Biological Research (IIBR) has made ‘significant’ progress in creating a Covid-19 vaccine prototype and preparations are underway for animal testing, said Prime Minister Benjamin Netanyahu.